Researcher Profile Statistics: Abou ela, Hanaa
Geo Map
Region
#
EU - Europe
13
AF - Africa
5
NA - North America
2
Unknown
30
Total
50
Country
#
RU - Russian Federation
10
EG - Egypt
5
DE - Germany
2
US - United States of America
2
FI - Finland
1
Unknown
30
Total
50
City
#
Al Fayyum
2
Cairo
2
Jacksonville
1
Pasadena
1
Unknown
44
Total
50
Most viewed items
#
ID: 169828 - COMPARATIVE STUDY BETWEEN OXYGEN THERAPY AND RUTIN AS AN ANTIOXIDANT IN HYPERLIPIDEMIC RATS
28
Total
28
Most type viewed
#
ID: all -
50
ID: other -
0
ID: journal -
22
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
72
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2019
0 0
0 0 0 0
1 1 1 0
0 0
3
2020
1 0
0 0 0 0
0 0 0 1
4 3
9
2021
2 1
2 2 0 0
0 0 0 0
1 0
8
2022
1 1
0 0 0 0
0 0 0 0
0 1
3
2023
0 0
1 0 2 0
1 1 0 1
0 2
8
2024
0 0
3 7 1 0
1 0 0 0
0 0
12
Ever
50
Geo Map
Region | # |
---|---|
EU - Europe | 13 |
AF - Africa | 5 |
NA - North America | 2 |
Unknown | 30 |
Total | 50 |
Country | # |
---|---|
RU - Russian Federation | 10 |
EG - Egypt | 5 |
DE - Germany | 2 |
US - United States of America | 2 |
FI - Finland | 1 |
Unknown | 30 |
Total | 50 |
City | # |
---|---|
Al Fayyum | 2 |
Cairo | 2 |
Jacksonville | 1 |
Pasadena | 1 |
Unknown | 44 |
Total | 50 |
Most viewed items | # |
---|---|
ID: 169828 - COMPARATIVE STUDY BETWEEN OXYGEN THERAPY AND RUTIN AS AN ANTIOXIDANT IN HYPERLIPIDEMIC RATS | 28 |
Total | 28 |
Most type viewed | # |
---|---|
ID: all - | 50 |
ID: other - | 0 |
ID: journal - | 22 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 72 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
2020 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 3 | 9 |
2021 | 2 | 1 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 8 |
2022 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 |
2023 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 1 | 0 | 1 | 0 | 2 | 8 |
2024 | 0 | 0 | 3 | 7 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12 |
Ever | 50 |